Investor News Release

Print Print  Email Email 
 Bookmark


<< Back
Health Management Associates, Inc. Reports Second Quarter Earnings

NAPLES, Fla.--(BUSINESS WIRE)--Aug. 4, 2008--Health Management Associates, Inc. (NYSE:HMA) today announced its consolidated financial results for the second quarter ended June 30, 2008. HMA reported net revenue of $1,105.3 million; earnings before interest, income taxes, depreciation, amortization, gains on sales of assets, refinancing costs and minority interests ("EBITDA") of $163.3 million; income from continuing operations of $21.9 million; net income of $12.4 million; diluted earnings per share ("EPS") of $0.05; diluted EPS from continuing operations of $0.09; and diluted EPS from continuing operations excluding refinancing costs and gains from the sales of assets (as shown in the accompanying table) of $0.10.

For continuing operations, compared to the prior year's second quarter, net revenue increased 3.9%; net revenue per adjusted admission increased 5.4%; adjusted admissions, reflecting total admissions adjusted for outpatient volume, decreased 1.5% (approximately 0.8% from fewer uninsured); admissions decreased 3.8% (approximately 0.8% from fewer uninsured); emergency room visits increased 1.6%; and surgeries decreased 0.8%. EBITDA from continuing hospital operations for the quarter was $183.5 million, which represented a margin of 16.6%.

"While patient volumes in the second quarter declined, we believe the changes were due in part to short-term issues that we have begun to address," said Burke Whitman, HMA's President and Chief Executive Officer, "and we minimized the impact upon earnings and cash flow through focused managerial discipline."

"I am particularly encouraged by the unambiguous progress we are making toward achieving our new vision to lead the industry in quality and satisfaction within two to three years. We had a long way to go in a number of our markets when we launched the Company's new direction on January 1, 2008, but we have made sizable improvements to quality and patient satisfaction. As we continue to improve in quality and patient satisfaction we expect to earn stronger patient and physician loyalty to our hospitals, resulting in meaningful volume growth beginning within one to two years, possibly sooner."

Provision for doubtful accounts, or bad debt expense, was $124.8 million, or 11.3% of net revenue, for the quarter compared to $142.7 million, or 13.4% of net revenue, for the same quarter a year ago and $129.0 million, or 11.2% of net revenue, for the first quarter ended March 31, 2008. The provision for doubtful accounts for the quarter ended June 30, 2007 included $39.0 million of additional reserves to reflect a decline in the collectibility of accounts receivable from uninsured patients.

Uninsured discounts from continuing operations for the quarter were $149.7 million compared to $147.7 million for the same quarter a year ago, and charity/indigent care write-offs for the quarter were $20.3 million, compared to $18.3 million for the same period a year ago. The sum of uninsured discounts, charity/indigent write-offs and bad debt expense, as a percent of the sum of net revenue, uninsured discounts and charity/indigent write-offs, was 23.1% for the second quarter, compared to 25.1% for the same quarter a year ago.

Cash flow from continuing operating activities for the six month period ended June 30, 2008 was $286.2 million, after cash interest and cash tax payments aggregating $83.4 million.

As previously announced on May 21, 2008, during the second quarter HMA completed a $250.0 million private placement of convertible senior subordinated notes due 2028. The notes pay interest semi-annually at a rate of 3.75% per annum. The notes are convertible into cash and, in select circumstances, shares of the Company's common stock, or a combination thereof, calculated on a proportionate basis over a 20 trading day observation period at a base conversion rate of 85.0340 shares per $1,000 principal amount of notes, which is equal to a base conversion price of approximately $11.76 per share, subject to adjustment upon the occurrence of certain events.

HMA utilized the net proceeds from the offering together with additional cash-on-hand to repurchase, in the open market, approximately $292.0 million of HMA's 4.375% convertible senior subordinated notes due 2023, leaving approximately $282.7 million of the 4.375% convertible senior subordinated notes outstanding as of June 30, 2008.

On August 1, 2008, holders of HMA's 4.375% convertible senior subordinated notes exercised a put-right and HMA used cash-on-hand to purchase approximately $282.5 million in principal value or 99.9% of the notes outstanding.

HMA also reported that it has updated its fiscal 2008 diluted EPS from continuing operations objective range to be between $0.41 and $0.47, excluding the previously reported gain from the Novant Health joint venture transaction and other items. This new EPS objective is based on a net revenue objective range of $4.4 to $4.6 billion, and an admissions decrease for the full year of between 1% and 3%.

HMA's management team will hold a conference call to discuss HMA's consolidated financial results and the contents of this press release on Tuesday, August 5, 2008 at 11:00 a.m. ET. Investors are invited to access the webcast via HMA's website located at www.hma.com or via www.streetevents.com or join the conference call by dialing 877-476-3476. HMA will archive a copy of the audio webcast, along with any related information that HMA may be required to provide pursuant to Securities and Exchange Commission rules, on its website under the heading "Investor Relations," for a period of 60 days following the conference call.

HMA's mission is the delivery of compassionate and high quality health care services that improve the quality of life for its patients, physicians, and the communities it serves. HMA owns and operates 57 hospitals, with approximately 8,100 licensed beds, in non-urban communities located throughout the United States. All references to "HMA" or the "Company" used in this release refer to Health Management Associates, Inc. or its affiliates.

Certain statements contained in this release, including, without limitation, statements containing the words "believes," "anticipates," "intends," "expects," "optimistic," "objective," and words of similar import, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may include projections of revenue, income or loss, capital expenditures, debt structure, bad debt expense, capital structure, or other financial items, statements regarding the plans and objectives of management for future operations, statements of future economic performance, statements of the assumptions underlying or relating to any of the foregoing statements, and other statements which are other than statements of historical fact.

Statements made throughout this release are based on current estimates of future events, and HMA has no obligation to update or correct these estimates. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially as a result of these various factors.

                  HEALTH MANAGEMENT ASSOCIATES, INC.
                  CONSOLIDATED STATEMENTS OF INCOME
         (unaudited, in thousands, except per share amounts)


                            Three Months Ended     Six Months Ended
                                 June 30,              June 30,
                           --------------------- ---------------------
                              2008       2007       2008       2007
                           ---------- ---------- ---------- ----------

Net revenue                $1,105,299 $1,064,104 $2,257,871 $2,171,440

Operating expenses:
   Salaries and benefits      448,617    424,990    916,420    857,836
   Supplies                   149,248    146,097    306,121    299,974
   Provision for doubtful
    accounts                  124,837    142,734    253,807    261,542
   Depreciation and
    amortization               59,626     52,364    117,084    102,661
   Rent expense                22,681     20,384     44,816     40,808
   Other operating expenses   196,637    192,152    391,810    378,813
                           ---------- ---------- ---------- ----------

Total operating expenses    1,001,646    978,721  2,030,058  1,941,634
                           ---------- ---------- ---------- ----------

Income from operations        103,653     85,383    227,813    229,806

Other income (expense):
   Gains on sales of assets
    including minority
    equity interests, net       6,184      2,586    209,504      3,259
   Interest expense          (58,656)   (61,625)  (120,860)   (94,867)
   Refinancing and debt
    modification costs       (10,834)          -   (11,463)      (761)
                           ---------- ---------- ---------- ----------
Income from continuing
 operations before minority
 interest and income taxes     40,347     26,344    304,994    137,437
Minority interests in
 earnings of consolidated
 entities                     (5,385)      (217)    (6,185)      (907)
                           ---------- ---------- ---------- ----------

Income from continuing
 operations before income
 taxes                         34,962     26,127    298,809    136,530
Income tax expense           (13,039)   (10,131)  (115,278)   (52,914)
                           ---------- ---------- ---------- ----------

Income from continuing
 operations                    21,923     15,996    183,531     83,616
Loss from discontinued
 operations, net of income
 taxes                        (9,526)    (4,090)   (37,258)    (6,671)
                           ---------- ---------- ---------- ----------

Net income                 $   12,397 $   11,906 $  146,273 $   76,945
                           ========== ========== ========== ==========

Earnings (loss) per share:
  Basic :
     Continuing operations $     0.09 $     0.07 $     0.75 $     0.35
     Discontinued
      operations               (0.04)     (0.02)     (0.15)     (0.03)
                           ---------- ---------- ---------- ----------

     Net income            $     0.05 $     0.05 $     0.60 $     0.32
                           ========== ========== ========== ==========

  Diluted :
     Continuing operations $     0.09 $     0.07 $     0.75 $     0.34
     Discontinued
      operations               (0.04)     (0.02)     (0.15)     (0.03)
                           ---------- ---------- ---------- ----------

     Net income            $     0.05 $     0.05 $     0.60 $     0.31
                           ========== ========== ========== ==========

Dividends per share        $        - $        - $        - $    10.00
                           ========== ========== ========== ==========

Weighted average number of
   shares outstanding:
     Basic                    243,268    242,355    243,229    242,016
     Add: Stock-based
      compensation
      arrangements              2,510      4,438      1,528      3,592
      Convertible debt              -          1          -          1
                           ---------- ---------- ---------- ----------
     Diluted                  245,778    246,794    244,757    245,609
                           ========== ========== ========== ==========



                  HEALTH MANAGEMENT ASSOCIATES, INC.
                CONSOLIDATED STATEMENTS OF CASH FLOWS
                      (unaudited, in thousands)

                                             Six Months Ended June 30,
                                             -------------------------
                                                 2008         2007
                                             ------------ ------------
Cash flows from operating activities:
   Net income                                $   146,273  $    76,945
   Adjustments to reconcile net income to net
    cash provided by continuing operating
    activities:
      Depreciation and amortization              120,636      105,079
      Provision for doubtful accounts            253,807      261,542
      Stock-based compensation expense             8,732        9,860
      Minority interests in earnings of
       consolidated entities                       6,185          907
      Gains on sales of assets, including
       minority equity interests, net           (209,504)      (3,259)
      Refinancing and debt modification costs     11,463          761
      Long-lived asset impairment charge             921            -
      Deferred income tax expense (benefit)       56,687      (42,058)
   Changes in assets and liabilities of
    continuing operations:
      Accounts receivable                       (260,941)    (285,082)
      Supplies and prepaid expenses               (7,293)         389
      Prepaid and recoverable income taxes
       and income taxes payable                  100,773       38,958
      Deferred charges and other long-term
       assets                                        965       (2,882)
      Accounts payable                             9,561       47,044
      Accrued expenses and other current
       liabilities                                12,047       (6,662)
      Other long-term liabilities                 (1,321)      16,207
   Equity compensation excess income tax
    benefit                                            -         (273)
   Loss from discontinued operations, net of
    income taxes                                  37,258        6,671
                                             ------------ ------------
Net cash provided by continuing operating
 activities                                      286,249      224,147
                                             ------------ ------------

Cash flows from investing activities:
   Acquisitions of minority interests and
    other                                         (2,420)     (36,127)
   Additions to property, plant and equipment    (93,512)    (144,098)
   Proceeds from sales of assets and
    insurance recoveries                           7,334       21,937
   Proceeds from sale of discontinued
    operations                                     3,500            -
   (Increases) decreases in restricted funds,
    net                                            2,780      (12,267)
                                             ------------ ------------
Net cash used in continuing investing
 activities                                      (82,318)    (170,555)
                                             ------------ ------------

Cash flows from financing activities:
   Proceeds from long-term debt, net             244,452    2,706,735
   Principal payments on debt and capital
    lease obligations                           (438,197)    (313,655)
   Proceeds from exercises of stock options            -       24,719
   Payments of financing costs                       (88)      (3,277)
   Investments by minority shareholders          302,938        8,456
   Cash distributions to minority
    shareholders                                  (2,287)      (2,397)
   Payments of cash dividends                          -   (2,425,217)
   Equity compensation excess income tax
    benefit                                            -          273
                                             ------------ ------------
Net cash provided by (used in) continuing
 financing activities                            106,818       (4,363)
                                             ------------ ------------

Net increase in cash and cash equivalents
 before discontinued operations                  310,749       49,229
Net decrease in cash and cash equivalents
 from discontinued operations:
   Operating activities                          (19,893)      (2,570)
   Investing activities                             (311)      (2,711)
   Financing activities                              (46)        (350)
                                             ------------ ------------

Net increase in cash and cash equivalents        290,499       43,598
Cash and cash equivalents at beginning of
 period                                          123,987       66,814
                                             ------------ ------------

Cash and cash equivalents at end of period   $   414,486  $   110,412
                                             ============ ============

                  HEALTH MANAGEMENT ASSOCIATES, INC.
                CONDENSED CONSOLIDATED BALANCE SHEETS
                            (in thousands)

                                      June 30,            December 31,
                                        2008                  2007
                                     ---------------------------------
Assets
Current Assets:
  Cash and cash equivalents          $  414,486            $  123,987
  Accounts receivable, net              624,122               627,879
  Other current assets                  220,549               287,404
  Assets of discontinued
   operations                            48,129                79,150
Property, plant and
 equipment, net                       2,405,927             2,403,746
Restricted funds                         63,831                76,179
Other assets                          1,038,839             1,045,574
                                     -----------          ------------

                                     $4,815,883            $4,643,919
                                     ===========          ============

Liabilities and
 Stockholders' Equity
Current liabilities                  $  748,049            $  597,432
Deferred income taxes                   129,224                70,457
Other long-term liabilities             310,213               308,210
Minority interests                      123,016                20,223
Long-term debt                        3,266,580             3,566,569
Stockholders' equity                    238,801                81,028
                                     -----------          ------------

                                     $4,815,883            $4,643,919
                                     ===========          ============



                             Three Months Ended    Six Months Ended
                                  June 30,             June 30,
                            -------------------- ---------------------
                              2008      2007       2008       2007
                            -------- ----------- -------- ------------
Total Hospitals(a)
Occupancy                      44.2%       44.8%    47.4%        47.0%
Patient Days                317,431     323,639  684,528      677,974
Admissions                   73,809      76,757  157,360      159,288
Adjusted Admissions         129,749     131,684  270,817      269,260
Average Length of Stay          4.3         4.2      4.4          4.3
Surgeries                    69,649      70,187  140,175      140,802
Outpatient Revenue
 Percentage                    48.8%       48.0%    47.7%        48.2%
Inpatient Revenue
 Percentage                    51.2%       52.0%    52.3%        51.8%

(a) Continuing Operations

                  HEALTH MANAGEMENT ASSOCIATES, INC.
      SUPPLEMENTAL CONSOLIDATED STATEMENTS OF INCOME INFORMATION
                      (unaudited, in thousands)

                         Three Months Ended       Six Months Ended
                              June 30,                June 30,
                       ----------------------- -----------------------
                        2008 (a)    2007 (a)    2008 (a)    2007 (a)
                       ----------- ----------- ----------- -----------

Net revenue            $1,105,299  $1,064,104  $2,257,871  $2,171,440

Less acquisitions,
 corporate and other            -           -      32,773      21,028
                       ----------- ----------- ----------- -----------

  Same hospital net
   revenue             $1,105,299  $1,064,104  $2,225,098  $2,150,412
                       =========== =========== =========== ===========

Income from continuing
 operations before
 income taxes          $   34,962  $   26,127  $  298,809  $  136,530

Adjustments:
  Interest expense         58,656      61,625     120,860      94,867
  Gains on sales of
   assets, including
   minority equity
   interests               (6,184)     (2,586)   (209,504)     (3,259)
  Depreciation and
   amortization            59,626      52,364     117,084     102,661
  Minority interests
   in earnings of
   consolidated
   entities                 5,385         217       6,185         907
  Refinancing and debt
   modification costs      10,834           -      11,463         761
                       ----------- ----------- ----------- -----------

EBITDA (b)                163,279     137,747     344,897     332,467

Adjustment for
 acquisitions,
 corporate and other       20,229      19,657      42,632      49,709
                       ----------- ----------- ----------- -----------

  Same hospital EBITDA $  183,508  $  157,404  $  387,529  $  382,176
                       =========== =========== =========== ===========


  Same hospital EBITDA
   margins =
  Same hospital EBITDA
   / same hospital
  net revenue (b)            16.6%       14.8%       17.4%       17.8%
                       =========== =========== =========== ===========

(a) Continuing operations.

(b) EBITDA is defined as earnings before interest, refinancing costs,
 income taxes, depreciation and amortization, gains and losses on
 sales of assets and minority interests. EBITDA margin is defined as
 EBITDA divided by net revenue. EBITDA does not represent cash flows
 from operations as defined by generally accepted accounting
 principles in the United States, commonly known as GAAP, and should
 not be considered as either an alternative to net income or as an
 indicator of HMA's operating performance or as an alternative to cash
 flows as a measure of HMA's liquidity. Nevertheless, HMA believes
 that providing non-GAAP information regarding EBITDA is important for
 investors and other readers of HMA's financials statements, as it
 provides a measure of HMA's liquidity. In addition, EBITDA is
 commonly used as an analytical indicator within the health care
 industry and HMA's debt facilities contain covenants that use EBITDA
 in their calculations. Because EBITDA is not a measurement determined
 in accordance with GA


                  HEALTH MANAGEMENT ASSOCIATES, INC.
      SUPPLEMENTAL CONSOLIDATED STATEMENTS OF INCOME INFORMATION
         (unaudited, in thousands, except per share amounts)

The following tables provide information regarding income from
 continuing operations, excluding the impact of the gains on sales of
 assets and minority interests and refinancing costs.  These tables
 are a non-GAAP presentation; nonetheless, HMA believes that providing
 this detail is beneficial to investors and other readers of HMA's
 financial statements due to the significant impact these items had on
 income from continuing operations.

                         For the Three Months Ended June 30, 2008
                    --------------------------------------------------

                                  Gains on     Refinancing
                               Sales of Assets   and Debt     Total,
                    Continuing  and Minority   Modification     As
                    Operations    Interests       Costs      Reported
                    ---------- --------------- ------------ ----------

Income from
 continuing
 operations before
 income taxes       $  39,612  $        6,184  $   (10,834) $  34,962

Income tax expense    (14,773)         (2,307)       4,041    (13,039)
                    ---------- --------------- ------------ ----------

Income from
 continuing
 operations         $  24,839  $        3,877  $    (6,793) $  21,923
                    ========== =============== ============ ==========


Earnings per share:

   Basic            $    0.10  $         0.02  $     (0.03) $    0.09
                    ========== =============== ============ ==========

   Diluted          $    0.10  $         0.02  $     (0.03) $    0.09
                    ========== =============== ============ ==========



                          For the Six Months Ended June 30, 2008
                    --------------------------------------------------

                                  Gains on     Refinancing
                               Sales of Assets   and Debt     Total,
                    Continuing  and Minority   Modification     As
                    Operations    Interests       Costs      Reported
                    ---------- --------------- ------------ ----------

Income from
 continuing
 operations before
 income taxes       $ 100,768  $      209,504  $   (11,463) $ 298,809

Income tax expense    (38,875)        (80,825)       4,422   (115,278)
                    ---------- --------------- ------------ ----------

Income from
 continuing
 operations         $  61,893  $      128,679  $    (7,041) $ 183,531
                    ========== =============== ============ ==========


Earnings per share:

   Basic            $    0.25  $         0.53  $     (0.03) $    0.75
                    ========== =============== ============ ==========

   Diluted          $    0.25  $         0.53  $     (0.03) $    0.75
                    ========== =============== ============ ==========

CONTACT: Health Management Associates, Inc., Naples
John C. Merriwether
Vice President of Financial Relations
239-598-3131

SOURCE: Health Management Associates, Inc.